DJ Vertex Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ shed 1.55% to $508.34 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.17% to 7,650.50 and the Dow Jones Industrial Average falling 0.18% to 51,682.64.
Vertex Pharmaceuticals Inc. closed 9.27% below its 52-week high of $560.25, which the company reached on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as AbbVie Inc. $(ABBV)$ fell 0.02% to $263.96, Krystal Biotech Inc. (KRYS) fell 0.61% to $336.67, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 5.32% to $16.03.
Data source: Dow Jones Market Data, FactSet. Data compiled September 18, 2026.